Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
₹ 25.72
Key Takeaways
Risk factor
Very poor trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Strong growth
Data is available to registered users only
Data is available to registered users only
About
Sudarshan Pharma Industries Ltd. engages in the provision of specialty chemicals, intermediates, and active pharmaceuticals ingredients. The firm outsourced its supplies to provide products to clients in India and abroad. It also involved in contract manufacturing, outsource and supplies of generic pharma formulation, and medicines to healthcare institution, government, NGO, and hospitals. The company was...
Company Valuation
From both historical and forecast perspectives, the stock is overpriced compared to similar stocks. In particular, the stock is overpriced on P/E, of fair value on EV/EBI
Data is available to registered users only
Buy
Sell